BS42023 L3+4 Flashcards

1
Q

what are the primary symptoms of PD? (4)

A
  • Muscle rigidity or stiffness
  • Resting rhythmic tremor
  • Bradykinesia (slowing of physical movement)
  • Postural instability/abnormality
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the secondary symptoms of PD? (7)

A
  • depression
  • dementia/confusion
  • speech and swallowing difficulties
  • drooling
  • dizziness
  • impotence
  • urinary frequency and constipation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what structures make up the basal ganglia? (5)

A
  1. Caudate
  2. Putamen
  3. Globus pallidus (internal and external segments)
  4. Subthalamic nucleus
  5. Substantia nigra (pars compacta and reticulata)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the key function of the basal ganglia?

A

the initiation and direction of voluntary movement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the simplified circuitry of the basal ganglia?

A

cortex –> striatum (caudate then putamen) –> globus pallidus (internal segment) –> thalamus –> cortex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the neuropathological hallmarks of PD? (2)

A
  1. Loss of nigrostriatal DA neurons

2. presence of Lewy bodies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

where are the cell bodies of the nigrostriatal DA neurons?

A

in the substantia nigra pars compacta (project to the putamen)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

why does SNpc depigmentation occur in PD?

A

due to the loss of SNpc DA neurons which have neuromelanin in them

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

on the onset of PD what proportion of putamen and SNpc DA neurons have depleted?

A

80% Putamen, 60% SNpc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are other neurochemical changes that occur in PD?

A

Neurodegeneration and LB formation occurs in;

  • noradrenergic neurons of the Locus coeruleus
  • serotonergic neurons in the Raphe nucleus
  • cholinergic neurons in the dorsal motor nucleus of the vagus.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are Lewy bodies?

A

intraneuronal proteinaceous cytoplasmic inclusions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is a major component of Lewy bodies?

A

fibrillar a-synuclein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what do a-synuclein knockout mice indicate?

A

a-synuclein is involved in synaptic vesicle recycling and DA neurotransmission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what does mutant a-synuclein result in? (3)

A
  • intraneuronal inclusions
  • mitochondrial DNA damage
  • apoptosis of neocortical, brainstem and motor neurons
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what does Parkin do?

A

it is an important enzyme that tags target proteins with ubiquitin for degradation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is UCH-L1 involved in?

A

catalysis hydrolysis of C-terminal ubiquityl esters and involved in recycling ubiquitin ligated to misfolded proteins.

17
Q

what does DJ-1 do?

A

. DJ-1 is thought to be a cellular monitor of oxidative stress

18
Q

describe the ubiquitin-proteasome system (5)

A
  • Ubiquitin monomers (Ub) are activated by E1 and transferred to Ub-conjugating enzyme (E2).
  • Proteins are recognised by E3 ligase (parkin) which transfers to Ub to target protein.
  • Ub monomers are attached to lysine residue (K) causing poly Ub chain formation.
  • Poly Ub chains are linked by K29/K48 target proteins for degradation- producing small peptide fragments.
  • Poly Ub chains are recycled to free monomers by enzymes like UCH-L1 for subsequent rounds of ubiquitination.
19
Q

what does mutant LRRK2 do?

A

mutant LRRK2 interferes with cytoskeletal motility and vesicular trafficking events

20
Q

what are the two main hypotheses of mechanisms of PD?

A
  • Misfolding and aggregation of proteins are instrumental in death of SNpc DA neurons.
  • Mitochondrial dysfunction and consequent oxidative stress, lead to cell death.
21
Q

what is the evidence for misfolding and aggregation of proteins?

A

Abnormal deposits of protein in brain tissue is a feature of several neurodegenerative disorders including PD. Although composition and localisation of protein aggregates differs from disease to disease, aggregation of proteins is a common feature.

22
Q

what is the evidence for mitochondrial dysfunction and oxidative stress?

A

Defects in oxidative phosphorylation in PD suggested as MPTP blocks mitochondrial electron transport chain by inhibiting complex I (NADH dehydrogenase). Abnormalities in mitochondrial complex I have also been identified in PD.

23
Q

what are the effects of complex I inhibition?

A

Inhibition of complex I increases ROS superoxide. This forms toxic hydroxyl radicals or reacts with NO to form peroxinitrite. These cause cellular damage by reacting with nucleic acids, proteins and lipids.

24
Q

what is the evidence for programmed cell death in PD?

A

There is an increase in the number of Bax-positive SNpc DA neurons in PD. Other molecular markers of PCD are also altered in PD including caspase-8, caspase-9 and Bcl-xL. (post-mortem tissues)

25
Q

what are the main animal models of PD?

A
Toxin-based models:
-	6-OHDA
-	Paraquat
-	Rotenone
-	MPTP
Gene-based models:
-	Synuclein
-	Parkin
-       LRRK2
-       DJ-1
26
Q

what are the pros and cons of the 6-OHDA model?

A

Pros:
Good model for assessing anti-PD actions of new drugs as unilateral striatal lesion causes quantifiable (related to degree of lesion/how many cells have died) asymmetric circling behaviour in animals. (administer to just one hemisphere of brain).

Cons:
Not clear if the mechanism of cell death is similar to human PD.
6-OHDA-induced pathology different from PD (formation of Lewy bodies-can’t look at Lewy body contribution to disease).
Pathology also varies depending on injection site of 6-OHDA. Need to know exactly where you are injecting your toxin so you can compare with other studies in the field.

27
Q

what are the pros and cons of the MPTP model?

A

pros:
Low dose MPTP treated monkeys show preferential degeneration of putamen vs caudal DA nerve terminals, replicates what you see in humans. The regional pattern of MPTP-induced damage is similar to human PD (there is more cell loss in SNpc than in VTA. DA neuromelanin-containing cells are more susceptible to damage).

cons:
Other monoaminergic neurons (e.g. in locus coeruleus) are not damaged by MPTP. Similar to 6-OHDA model, classical Lewy bodies are not found in MPTP-intoxicated humans/monkeys.

28
Q

what are the pros and cons of the rotenone model?

A

Pros:
May be a good model for studying the relationship between aggregate formation and cell death.

Cons:
Rotenone has widespread neurotoxic actions- it is not DA selective although these are the main target for its action within the brain.

29
Q

what are the pros and cons of the paraquat model?

A

Pros:
This model may be a useful model to study the role of a-synuclein in neuro-degeneration as it reliably causes DA cell loss and a-synuclein positive inclusions).

Cons:
It is not known if DA toxicity is selective or if other neurons are affected.